MATHEMATICAL MODEL FOR PREDICTING SURVIVAL IN PATIENTS WITH  TRIPLE NEGATIVE BREAST CANCER

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/9572

Full metadata record

DC Field	Value	Language
dc.contributor.author	Atakhanova N. E., Almuradov A., Almuradova D. M., Ziyaev Sh. V	-
dc.date.accessioned	2023-12-06T13:04:39Z	-
dc.date.available	2023-12-06T13:04:39Z	-
dc.date.issued	2023	-
dc.identifier.issn	2776-0960	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/9572	-
dc.description.abstract	Triple negative breast cancer (TNBC) has a more aggressive clinical course compared to other breast cancer subtypes. The presence of a triple negative receptor status causes the ineffectiveness of such types of targeted treatment as hormonal therapy and targeted therapy with Herceptin , in contrast to luminal and Her-2/ neu -positive tumors. In this regard, chemotherapy today remains the only accepted method of systemic treatment in this category of patients. Over the past few years, great advances have been made in the comprehensive treatment of TNBC. But, despite this, TN breast cancer remains one of the aggressive forms of malignant breast tumors with a high level of metastasis and low survival compared to other subtypes of breast cancer	en_US
dc.language.iso	en_US	en_US
dc.publisher	Researchjet Journal of Analysis and Inventions	en_US
dc.subject	triple negative breast cancer , immunohistochemistry, androgen receptor , mathematical models	en_US
dc.title	MATHEMATICAL MODEL FOR PREDICTING SURVIVAL IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
1-7.pdf	MATHEMATICAL MODEL FOR PREDICTING SURVIVAL IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER	333.23 kB	Adobe PDF	View/Open

DSpace JSPUI